A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
About two thirds of all human breast cancer cases are estrogen receptor positive. The drug of first choice for these patients is tamoxifen. However, about half of the recurrences after removal of the primary tumor are or become resistant to this drug. While many...
Saved in:
| Main Authors: | Renée de Leeuw, Jacques Neefjes, Rob Michalides |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.4061/2011/232435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tamoxifen Molecular Targets Different From Estrogen Receptors
by: T. A. Bogush, et al.
Published: (2020-05-01) -
PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells
by: Wenju Mo, et al.
Published: (2025-06-01) -
Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
by: Takayuki Watanabe, et al.
Published: (2021-01-01) -
New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy
by: T. A. Bogush, et al.
Published: (2020-05-01) -
ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01)